This site is intended for Healthcare Professionals only

MHRA

linctus-1280x720

Codeine linctus to be reclassified as POM because of risk of abuse

Codeine linctus is to be reclassified to a prescription-only medicine due to the risk of abuse, dependency and overdose, the MHRA has announced.

20 Feb 2024 , 1 Min Article

gene-1280x720

Genetic biobank recruiting patients on DOACs in pilot study

By collecting genetic samples, the Yellow Card Biobank aims to determine whether a suspected side effect was caused by a specific genetic trait.

13 Feb 2024 , 1 Min Article

safety-alert-summary

New valproate safety materials released by MHRA

Updated regulatory measures are now in place to reduce the known harms from valproate.

09 Feb 2024 , 3 Min Article

online-meds-1280x720

Illegal medicines worth £30 million seized in the UK in 2023

The MHRA, working with law enforcement partners, says it seized more than 15.5 million doses of illegally traded medicines with a street value of more than £30 million during 2023.

30 Jan 2024 , 1 Min Article

ofloxacin-1280x720

New restrictions on prescribing of fluoroquinolones

Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate, the MHRA advises after safety review

23 Jan 2024 , 1 Min Article

valproate-1280x720

New study suggests risk of disorders in children fathered by men taking valproate

The MHRA advises that, as a precaution, male patients on valproate who are planning a family in the next year should talk to their healthcare professional

16 Jan 2024 , 1 Min Article

warning-1280

MHRA issues warning about missing Cozaar 100mg tablets information

The regulator said the sentence ‘grapefruit juice should be avoided while taking Cozaar’ is missing in some patient information leaflets.

04 Jan 2024 , 1 Min Article

Recall 1280.jpg

MHRA recalls batches of eye gels after possible contamination

Batches of carbomer-containing lubricating eye gels branded Aacarb, Aacomer and Puroptics were recalled as a precaution.

28 Nov 2023 , 1 Min Article

painkiller-new-1280

Bristol Labs says there’s been no disruption in supply of co-codamol

The Medicines and Healthcare products Regulatory Agency partially suspended its manufacturing and wholesale distribution authorisations.

22 Nov 2023 , 1 Min Article

Weight loss 1280.jpg

Diabetes drug authorised for weight loss and weight management

Mounjaro, also known as tirzepatide, has been authorised by the MHRA for weight loss and weight management in people aged 18 and over.

10 Nov 2023 , 1 Min Article

fluoxetine-summary

UK seizes £84m in black market medicines through global partnership

MHRA and Interpol issue latest update on crackdown effort Operation Pangea

01 Nov 2023 , 1 Min Article

iso-1280x720

New prescribing rules for isotretinoin address safety concerns

Treatment with isotretinoin for patients under 18 must now be approved by two prescribers, under new MHRA rules.

31 Oct 2023 , 1 Min Article

pangea-1280x720

MHRA has seized £5 million of illegally traded medicines this year

This is the 15th year since the MHRA launched Operation Pangea, an initiative cracking down on medicines crime.

31 Oct 2023 , 1 Min Article

warning-1280

Falsified Ozempic pens at two wholesalers recalled, says MHRA

Falsified type 2 diabetes pens were discovered at two wholesalers and arrived in the country from legitimate suppliers.

25 Oct 2023 , 1 Min Article

white-tablets-summary

MHRA catches Maidenhead couple in £1.6m black market medicines ploy

Maidenhead couple found with drugs for breast cancer, ADHD, erectile dysfunction and hair loss

11 Sep 2023 , 1 Min Article

controlled-drugs-summary

Five charged in Dudley over ‘illegal online medicine sales’

Charges follow an MHRA investigation into illegally operating websites

01 Sep 2023 , 1 Min Article

Change privacy settings